[1] Cao Z,Li Z,Wang Y,et al.Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.Journal of viral hepatitis,2017,24 Suppl 1:57-65.
[2] Kladney RD,Bulla GA,Guo L,et al.GP73, a novel Golgi-localized protein upregulated by viral infection.Gene,2000,249:53-65.
[3] 彭桦,马薇,何前进,等.HBV激活Notch1信号通路上调GP73的表达.现代肿瘤医学,2017,25:3551-3554.
[4] 孙振宇,刘宁,何湘,等.二乙基亚硝胺诱导小鼠急性肝炎模型的建立.军事医学,2018,42:433-437.
[5] 刘宁,孙鹤鸣,赵怡雯,等.转化生长因子β上调肝癌中GP73表达的分子机制.生物技术通讯,2018,29:636-640.
[6] Yang Y,Liu Q,Li ZP,et al.GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.Carcino-genesis,2018,39:900-910.
[7] 王小华,相祎,王伟.肝细胞肝癌血清GP73和HMGB1的表达水平及其联合检测意义.肝脏,2018,23:914-917.
[8] 吴晓霞,周颜,张英,等.高尔基体蛋白73联合甲胎蛋白在原发性肝癌诊断中的应用.肝脏,2016,21:73-74.
[9] 彭友缘,刘建明.四项指标联合检测在原发性肝癌诊断中的临床意义.中国卫生标准管理,2018,9:41-43.
[10] Ai N,Liu W,Li ZG,et al.High expression of GP73 in primary hepatocellular carcinoma and its function in the assessment of transcatheter arterial chemoembolization.Oncology letters,2017,14:3953-3958.
[11] 赵睿,王启之,郑海伦.原发性肝癌患者TACE前后血清GP73的变化及意义.中华全科医学,2018,16:1623-1625.
[12] Hasan O,Harun E,Hüseyin T,et al.Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.Digestion,2011,83:83-88.
[13] Tian H,Liu MJ,Yao SH,et al.Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.Onco-target,2017,8:16498-16506.
[14] Tong M,Che N,Zhou L,et al.Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and rego-rafenib.Journal of hepatology,2018,69:826-839.
[15] 杨颖,张瑞丽,杨志芳,等.GP73调控PI3K/Akt通路介导肝癌细胞索拉非尼耐药机制的实验研究.中华全科医学,2019,17:6-9,90.
[16] HsinAn Chen, TsangChih Kuo,ChiFeng Tseng,et al.Angio-poietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma.Hepatology (Baltimore, Md.),2016,64:1637-1651.
[17] Wang W,Jia WD,Xu GL,et al.Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma.Digestive diseases and sciences,2009,54:2128-2136.
[18] Zhou L, Huang Y, Li J, et al. The mTOR pathway is asso-ciated with the poor prognosis of human hepatocellular carcinoma. Med Oncol, 2010, 27:255-261.
[19] Chen XX,Wang YA,Tao J,et al.mTORC1 up-regulates GP73 to promote proliferation and migration of hepatocellular carcinoma cells and growth of xenograft tumors in mice.Gastroenterology,2015,149:741-752.e14.
[20] Glenn S,Peter B,G Craig W,et al.Identification of novel clinical factors associated with hepatic fat accumulation in extreme obesity.Journal of obesity,2014,2014:368-210.
[21] Ye QH, Zhu WW,Zhang JB,et al.GOLM1 modulates EGFR/RTK cell surface recycling to drive hepatocellular carcinoma metastasis. Cancer Cell, 2016,30:444-458.
[22] Dong D, Zhong W, Sun Q,et al. Oxidative products from alcohol metabolism differentially modulates proinflammatory cytokine expression in Kupffer cells and hepatocytes. Cytokine, 2016,85:109-119.
[23] 刘宁,孙振宇,马雪平,等.GP73及肿瘤相关巨噬细胞在肝癌组织中的表达及临床意义.军事医学,2018,42:652-656.
[24] Cullen SJ, Fatemie S, Ladiges W.Breast tumor cells primed by endoplasmic reticulum stress remodel macrophage phenotype. Am J Cancer Res, 2013,3:196-210.
[25] Wei C,Yang X,Liu N,et al.Tumor Microenvironment Regulation by the Endoplasmic Reticulum Stress Transmission Mediator Golgi Protein 73 in Mice.Hepatology (Baltimore, Md.)2019,doi: 10.1002/hep.30540. |
